Targeted Therapy of Acute Myeloid Leukemia

Nonfiction, Health & Well Being, Medical, Specialties, Oncology, Medical Science, Pharmacology
Cover of the book Targeted Therapy of Acute Myeloid Leukemia by , Springer New York
View on Amazon View on AbeBooks View on Kobo View on B.Depository View on eBay View on Walmart
Author: ISBN: 9781493913930
Publisher: Springer New York Publication: November 20, 2014
Imprint: Springer Language: English
Author:
ISBN: 9781493913930
Publisher: Springer New York
Publication: November 20, 2014
Imprint: Springer
Language: English

This book provides an unprecedented overview of "Targeted Therapies" for acute myeloid leukemias. It aims at an almost comprehensive coverage of the diverse therapeutic strategies that have been developed during the last decade and are now being evaluated in early clinical trials. Paired and authoritative chapters by leading research scientists and clinicians explain basic concepts and clinical translation of topics that include the underlying genetic and proteomic abnormalities of AML, the development of novel nucleoside analogues, the roles of microRNAs, apoptosis regulators Bcl-2 and p53 and of critical cell signaling proteins such as PIM, FLT3, Raf/MEK, PI3K/AKT/mTOR and aurora kinases. Chapters on epigenetic mechanisms, nuclear receptors, cell surface antigens, the hypoxic leukemia microenvironment, stem cells and leukemia metabolism provide insights into leukemia cell vulnerabilities. Cell therapies utilizing T-, NK- and mesenchymal stem cells and progress in hematopoietic transplantation strategies round up this overview of the multi-dimensional therapeutic landscape in which leukemia specialists develop treatment strategies that are expected to make "leukemia history" in the near future.

View on Amazon View on AbeBooks View on Kobo View on B.Depository View on eBay View on Walmart

This book provides an unprecedented overview of "Targeted Therapies" for acute myeloid leukemias. It aims at an almost comprehensive coverage of the diverse therapeutic strategies that have been developed during the last decade and are now being evaluated in early clinical trials. Paired and authoritative chapters by leading research scientists and clinicians explain basic concepts and clinical translation of topics that include the underlying genetic and proteomic abnormalities of AML, the development of novel nucleoside analogues, the roles of microRNAs, apoptosis regulators Bcl-2 and p53 and of critical cell signaling proteins such as PIM, FLT3, Raf/MEK, PI3K/AKT/mTOR and aurora kinases. Chapters on epigenetic mechanisms, nuclear receptors, cell surface antigens, the hypoxic leukemia microenvironment, stem cells and leukemia metabolism provide insights into leukemia cell vulnerabilities. Cell therapies utilizing T-, NK- and mesenchymal stem cells and progress in hematopoietic transplantation strategies round up this overview of the multi-dimensional therapeutic landscape in which leukemia specialists develop treatment strategies that are expected to make "leukemia history" in the near future.

More books from Springer New York

Cover of the book Polycystic Ovary Syndrome by
Cover of the book Children in Pain by
Cover of the book Practical Imaging Informatics by
Cover of the book Advances in Energy Harvesting Methods by
Cover of the book Extrasynaptic GABAA Receptors by
Cover of the book Research Issues in Learning Disabilities by
Cover of the book Petrogenesis of Metamorphic Rocks by
Cover of the book Silicon-based Nanomaterials by
Cover of the book Trustworthy Execution on Mobile Devices by
Cover of the book Gene-Environment Interplay in Interpersonal Relationships across the Lifespan by
Cover of the book Primary Care Sleep Medicine by
Cover of the book Current Perinatology by
Cover of the book The Strength of Self-Acceptance by
Cover of the book Pocket Guide to Critical Care Pharmacotherapy by
Cover of the book Handbook of Pain and Palliative Care by
We use our own "cookies" and third party cookies to improve services and to see statistical information. By using this website, you agree to our Privacy Policy